Envision Healthcare (EVHC) Cut to “Hold” at ValuEngine

Envision Healthcare (NYSE:EVHC) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Sunday.

A number of other analysts have also recently commented on the stock. SunTrust Banks set a $40.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a research note on Thursday, December 21st. Jefferies Group set a $41.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a research note on Tuesday, December 19th. Piper Jaffray Companies began coverage on shares of Envision Healthcare in a research note on Wednesday, December 13th. They set a “neutral” rating and a $35.00 price target on the stock. Credit Suisse Group began coverage on shares of Envision Healthcare in a research note on Monday, December 11th. They set an “outperform” rating and a $36.00 price target on the stock. Finally, Mizuho set a $31.00 price target on shares of Envision Healthcare and gave the company a “neutral” rating in a research note on Friday, November 17th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the company. Envision Healthcare has an average rating of “Hold” and a consensus price target of $40.13.

Shares of Envision Healthcare (EVHC) opened at $34.56 on Friday. The company has a market cap of $4,177.92, a P/E ratio of -6.91, a P/E/G ratio of 1.16 and a beta of 0.57. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. Envision Healthcare has a 52 week low of $23.77 and a 52 week high of $73.00.

Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business’s quarterly revenue was up 142.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.13 earnings per share. research analysts predict that Envision Healthcare will post 2.49 earnings per share for the current fiscal year.

Envision Healthcare announced that its board has authorized a share buyback program on Monday, September 18th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 4.5% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in Envision Healthcare by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 11,471,402 shares of the company’s stock worth $718,912,000 after acquiring an additional 204,584 shares during the period. BlackRock Inc. increased its holdings in shares of Envision Healthcare by 2.1% in the 2nd quarter. BlackRock Inc. now owns 7,345,283 shares of the company’s stock worth $460,330,000 after buying an additional 147,652 shares during the last quarter. Maverick Capital Ltd. increased its holdings in shares of Envision Healthcare by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the last quarter. Janus Henderson Group PLC increased its holdings in shares of Envision Healthcare by 0.3% in the 3rd quarter. Janus Henderson Group PLC now owns 3,958,329 shares of the company’s stock worth $177,927,000 after buying an additional 13,242 shares during the last quarter. Finally, OZ Management LP bought a new position in shares of Envision Healthcare in the 3rd quarter worth $131,987,000.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/01/01/envision-healthcare-evhc-cut-to-hold-at-valuengine.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit